Overview


According to FutureWise analysis the market for cold and flu supplements in 2023 is US$ 17.06 billion, and is expected to reach US$ 41.1 billion by 2031 at a CAGR of 11.60%.

The safe and effective cold and flu supplements can be purchased at local pharmacies or online without the need for a prescription. These supplements are rarely used for common conditions. These supplements may include antihistamines, decongestants, and cough suppressants. After verification of age and identification, the pharmacists will give them to the customer. Acetaminophen and Aspirin are the most popular over-the-counter supplements. Non-prescription supplements, also known as over-the-counter supplements (OTC), are medications that don't require a prescription to be sold to consumers. These supplements can be used as directed by the label. These supplements can be purchased at gas stations, pharmacies, general stores, supermarkets and general stores in many countries. These supplements can only be dispensed by pharmacists after they verify age, identity, as well as the patient's knowledge about the product and its use. Minor health problems can be treated with non-prescription supplements like analgesics and dermatologics.

OTC supplements are subject to regulation and manufactured according to the New Drug Application (NDA), or OTC Monograph processes. Global demand for cold and flu products has increased due to a changing lifestyle as well as easier access to supplements via both online and offline stores. The demand for cold and flu products and over-the counter (OTC) medicines is also being driven by consumers' better understanding of the medicinal properties and benefits of natural ingredients. The world's increasing purchasing power is expected to increase the demand for immune health products such as cold and flu supplements. In order to prevent such diseases and boost immunity, the demand for cold and influenza supplements is increasing. The main purpose of cold and flu supplements is to boost immunity. Due to increasing consumer awareness of the health benefits of flu and cold supplements, the market is expected grow at a healthy pace.

Many countries have provided free flu vaccinations to their growing elderly population. These programs could limit the Cold and Flu Supplements Market growth in the future. However, the industry will see a rise in investment from manufacturers in product development which will increase sales of cold and influenza supplements. The market for cold and flu supplements will grow due to consumers' increasing awareness about seasonal diseases and increased spending on their health. Cold and Flu Supplements Market growth is being driven by the increasing use of OTC drugs in the developing regions. The Cold and Flu Supplements Market is expected to grow due to rising population and increasing disposable income.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cold and Flu Supplements Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cold and Flu Supplements Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • WAKUNAGA OF AMERICA CO., LTD.
  • Neurobiologix, Inc.
  • The Vitamin Shoppe
  • KLAIRE LABS
  • Nordic Naturals
  • Himalaya Global Holdings Ltd.
  • Nature's Way Products, LLC (Dr. Willmar Schwabe GmbHCo. KG)
  • FineVine
  • Flora Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • NOW Foods

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Natural Molecules
  • Herbal Extracts
  • Vitamins and Minerals

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Platformms
  • Other Distribution Channel

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Cold and Flu Supplements Market By Product Type, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cold and Flu Supplements Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Product Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cold and Flu Supplements Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cold and Flu Supplements Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Product Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Product Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cold and Flu Supplements Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Natural Molecules
        2. Herbal Extracts
        3. Vitamins and Minerals

  • 8.   Cold and Flu Supplements Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Platformms
        4. Other Distribution Channel

  • 9.   North America Cold and Flu Supplements Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Cold and Flu Supplements Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Cold and Flu Supplements Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Cold and Flu Supplements Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. WAKUNAGA OF AMERICA CO., LTD.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Neurobiologix, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. The Vitamin Shoppe
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. KLAIRE LABS
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Nordic Naturals
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Himalaya Global Holdings Ltd.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Nature's Way Products, LLC (Dr. Willmar Schwabe GmbHCo. KG)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. FineVine
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Flora Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Pfizer Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. GlaxoSmithKline plc
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
            11.4. Financial Overview
         11.5. Strategic Overview
        12. NOW Foods
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients